BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 19933662)

  • 1. Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients.
    Gomes AS; Rosove MH; Rosen PJ; Amado RG; Sayre JW; Monteleone PA; Busuttil RW
    AJR Am J Roentgenol; 2009 Dec; 193(6):1665-71. PubMed ID: 19933662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
    Gomes AS; Monteleone PA; Sayre JW; Finn RS; Sadeghi S; Tong MJ; Britten CD; Busuttil RW
    AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.
    Mabed M; Esmaeel M; El-Khodary T; Awad M; Amer T
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):492-9. PubMed ID: 19453695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
    Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M;
    AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma.
    Bayraktar Y; Balkanci F; Kayhan B; Uzunalimoglu B; Gokoz A; Ozisik Y; Gurakar A; Van Thiel DH; Firat D
    Hepatogastroenterology; 1996; 43(9):681-7. PubMed ID: 8799415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors.
    Lu W; Li Y; He X; Chen Y
    Hepatogastroenterology; 2003; 50(54):2079-83. PubMed ID: 14696468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
    Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL
    Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
    Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
    Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS
    J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necrosis and apoptosis in hepatocellular carcinoma following low-dose versus high-dose preoperative chemoembolization.
    Lu W; Li YH; He XF; Zhao JB; Chen Y; Mei QL
    Cardiovasc Intervent Radiol; 2008; 31(6):1133-40. PubMed ID: 18584240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma.
    Seki A; Hori S
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):555-62. PubMed ID: 21562932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma.
    Brown DB; Fundakowski CE; Lisker-Melman M; Crippin JS; Pilgram TK; Chapman W; Darcy MD
    J Vasc Interv Radiol; 2004 Nov; 15(11):1209-18. PubMed ID: 15525739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [External radiation and combined transcatheter arterial chemoembolization for unresectable primary liver cancer].
    Liu MZ; Wang XS; Cai L; Gu MF; Liu H; Li Q; Cui NJ; Zhang YQ; Li GH; Li JQ
    Ai Zheng; 2005 Jan; 24(1):82-6. PubMed ID: 15642207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging perfusion mismatch: a technique to verify successful targeting of liver tumors during transcatheter arterial chemoembolization.
    Lewandowski RJ; Tepper J; Wang D; Ibrahim S; Miller FH; Kulik L; Mulcahy M; Ryu RK; Sato K; Larson AC; Salem R; Omary RA
    J Vasc Interv Radiol; 2008 May; 19(5):698-705. PubMed ID: 18440458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.
    Sadick M; Haas S; Loehr M; Elshwi M; Singer MV; Brade J; Schoenberg SO; Diehl SJ
    Onkologie; 2010; 33(1-2):31-7. PubMed ID: 20164659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma.
    Shim SJ; Seong J; Han KH; Chon CY; Suh CO; Lee JT
    Liver Int; 2005 Dec; 25(6):1189-96. PubMed ID: 16343071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.
    Kim JH; Yoon HK; Kim SY; Kim KM; Ko GY; Gwon DI; Sung KB
    Aliment Pharmacol Ther; 2009 Jun; 29(12):1291-8. PubMed ID: 19392861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.
    Malagari K; Pomoni M; Kelekis A; Pomoni A; Dourakis S; Spyridopoulos T; Moschouris H; Emmanouil E; Rizos S; Kelekis D
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):541-51. PubMed ID: 19937027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.